began, anxiety and depression scores on the Dutch-AIMS had increased among participatingpatients who were experiencing high disease activity and decreased among those who were experiencing low disease activity.
Conclusions. Patients experiencing high disease activity did not derive more benefit from patient education than those experiencing low disease activity On the contrav, an increase of anxiety and depression is found in these patients. Further study is needed to confirm our findings.

INTRODUCTION
Persons with rheumatoid arthritis (RA) must face many physical, psychological, social, and economic problems (1) (2) (3) (4) (5) (6) (7) (8) . Beneficial effects of patient education on health behavior and on health status have been found in mixed populations of patients with different forms of rheumatic disease (9, 101 . Taal et a1 developed a self-management course for groups, based on the social learning theory of Bandura (11, 12) and a similarly based program of Lorig and colleagues (13,14). The results of this course were promising. Beneficial shortterm effects included improved knowledge and selfefficacy expectations about physical functioning, increased adherence to physical exercise therapy and relaxation exercise therapy, increased practice of selfmanagement activities, and an improvement in functional ability. No improvements were found in the frequency with which endurance exercises were performed, nor in pain, depression, or anxiety. After 14 months, there were still beneficial effects on knowl-0893-7524/97I$5.00 edge, adherence to physical exercise therapy, and selfefficacy expectations about physical functioning (15). Because RA patients with active disease are presumably confronted with more problems than those whose disease is in remission, we performed a retrospective investigation to determine whether level of disease activity was associated with the amount of benefit gained from the educational program. We considered outcomes with regard to adherence to treatment advice and health status.
PATIENTS AND METHODS
All outpatients between 21 and 65 years old, who had entered the practices of 3 rheumatologists less than 8 years ago and fulfilled the American College of Rheumatology (formerly the American Rheumatism Association) criteria for RA (16) were asked to participate. Informed consent was obtained, and patients were then allocated at random to an experimental or a control group. These groups were subdivided according to the Westergren erythrocyte sedimentation rate (ESR) value into a high disease activity subgroup (ESR > 28 mm/ hour) and a low disease activity subgroup (ESR 5 28 mm/hour). Other measures for disease activity determined were: C-reactive protein (CRP; mg/liter), hemoglobin (mmol/liter), and a thrombocyte count (number x 10g/liter). All patients continued their current treatments and were referred to physiotherapists for individual treatment and support. The experimental group attended 5 meetings for patient education. The program included 1) contracting, goal setting, and feedback 2) self-management and problem-solving; 3) information on RA and its treatment, including medication, physical exercise therapy, endurance exercise therapy, relaxation exercise therapy, and pain management; 4) communication skills; 5) coping with depression.
Age, disease duration, functional class according to Steinbrocker et a1 (17) , and adherence to physical, endurance, and relaxation exercise therapies (number of times per week) were ascertained by questionnaire at the beginning of the study. Health status was measured with the Dutch Arthritis Impact Measurement Scales (AIMS) and the Modified Health Assessment Questionnaire (M-HAQ). After 4 months, adherence, Dutch-AIMS, and M-HAQ were reassessed.
Dutch-AIMS is a Dutch language version of the AIMS health status questionnaire (18) (19) (20) . We used its 5 series of questions on physical health, the 2 series on psychological health, and the series on pain. The physical health series deal with mobility, physical activities, dexterity, household activities, and activities of daily living. The psychological health series deal with anxiety and depression. The range of scores for each series is from 0 to 10, where 0 represents good health and 10 poor health. Overall physical health and psychological health scores are obtained by adding the scores for their constituent dimensions.
The M-HAQ (21) is a short questionnaire that measures physical disability. Its scores range from l to 4, where 1 represents good function and 4 poor function, Statistics. The initial data of the experimental group had been compared with those of the control group by Tad et al(15). To validate ow classification of the patients into subgroups with high and low disease on the basis of ESR, we compared the CRP, the hemoglobin, and the thrombocyte count of the total high ESR group with those of the total low ESR group. In our study we compared the initial scores as well as the changes in the scores after 4 months in 4 pairs of subgroups. The Wilcoxon two sample test was used. Spearman's rank correlation coefficient was computed between disease duration and the psychological health series of the Dutch-AIMS in the total population, as well as between the disease duration and the 4 months' change in these series. The data of patients who withdrew from or dropped out of the study were not included in the analysis,
RESULTS
One hundred forty patients fulfilled the selection criteria. Seventy-five gave informed consent. Of these, 38 were allocated to the experimental group and 37 to the control group. There were 6 withdrawals from the experimental group and 7 from the control group. ESR was unavailable from 2 patients in the control group. There were no significant differences in age, disease duration, functional class, adherence, or health scores between the experimental and control groups at the beginning of the study (Table 1) .
In the total population there were 47 patients classified as having low disease activity, and 13 classified as having high disease activity. Mean values of CRP were 1 2 (SD 7) and 37 (SD 23) mg/liter in the respective groups (P < 0.001), of hemoglobin 8.5 (SD 0.7) and 7.9 (SD 0.9) mmol/ liter (P < 0.05), and of the thrombocyte count 265 (SD 55) and 311 (SD 72) X 10Q/liter (P < 0.05).
The high disease activity subgroup of the experimental group consisted of 7 patients, the low disease activity subgroup of 25. The high disease activity subgroup of the control group consisted of 6 patients, the low disease activity subgroup of 22. The only statistically significant difference between complementary subgroups at the beginning of the study was that disease duration was shorter in the low disease activity subgroup of the experimental group than in the high disease activity subgroup of that group ( Table 2) . The changes in the adherence scores of the 2 high disease activity subgroups after 4 weeks were not significantly different from those of their low disease activity complements. Neither were there significant differences between corresponding subgroups of the experimental and control groups in this regard ( Table 2) .
The score on the psychological dimension of the Dutch-AIMS of the high disease activity subgroup of the experimental group increased, while that of the low disease activity subgroup of the experimental group decreased; the difference between the changes from baseline in these subgroups was statistically significant. The correlation between the disease duration and the psychological dimension of the Dutch-AIMS in the total population at baseline was -0.03 (not significant). The correlation between the disease duration and the change from baseline in the psychological dimension was -0.003 (not significant). There were no statistically significant differences between the high disease activity subgroup of the control group and its low disease activity complement with regard to Dutch-AIMS and M-HAQ, and no statistically significant differences in this regard between the high disease activity subgroup in the experimental group and that in the control group. In the low disease activity subgroup of the experimental group, the M-HAQ score had decreased after 4 months; in the corresponding subgroup of the control group it had increased. This difference is statistically significant ( Table 2) .
DISCUSSION
It is conceivable that the effects of group education are not the same for all patients, or that some patients need a different approach than others. We expected patient education to be more beneficial for patients with high disease activity with regard to adherence or health status, but the results of our study did not support this expectation.
There is no consensus about how to measure disease activity (22-25). We chose the ESR for that purpose because it is an inexpensive and easily performed measure. The cut-off point of 28 mm/first hour is commonly used to help discriminate active disease from less active disease. Other measures for disease activity (CW, hemoglobin, and thrombocyte count) were different in the high and low disease activity groups, thus indicating the validity of our classification of patients into high and low disease activity groups on basis of the ESR cut-off point of 28 mm/first hour. Surprisingly, we found that patients with high disease activity became more anxious and depressed following patient education, while the other patients of the experimental group became less anxious and depressed. There is some concern about the reliability of this finding because of the small samples for the high disease activity experimental group (n = 7) and the high disease activity control group (n = 6). An additional concern is the difference in disease duration between the high and the low disease activity subgroup in the experimental group. However it is unlikely that this difference in disease duration has biased our results with regard to anxiety and depression, because disease duration did not correlate with the scores on the psychological dimension of the Dutch-AIMS at baseline (r = 0.03), nor with the changes from baseline in the same variable (r = -0.003).
The increase in anxiety and depression following patient education among patients with a high disease activity could be the result of increased awareness of (n = 25) (n = 6) (n = the consequences of the high disease activity for functional ability and its association with damage to the joints. The finding that these patients became more anxious and depressed does not appear to support the hypothesis that these are the patients that should benefit most. It is not clear, however, whether it should be taken as a positive or a negative effect. Is it a final outcome or will it be conducive to more effective modes of coping and hence to an improvement in health?
Because treatment with disease-modifying antirheumatic drugs is the only therapy that has been proven to reduce disease activity (26), improving adherence to this treatment should perhaps be included as an important and specific aim of patient education when patients experiencing high disease activity are involved.
The only other difference that we found, that M-HAQ scores improved more in the high disease activity subgroup of the experimental group than in the corresponding subgroup of the control group, is in line with the positive effects of patient education on disability found by Taal et a1 in their earlier study. Because of the small sample sizes, we may have missed other significant influences of disease activity on the effects of patient education on adherence or health status (Type 2 errors). Many studies have shown that increases in adherence and improvement of health status can be achieved with patient education (9,lO 
